IL15 and breast cancer: Recent work reported by Pavlakis et al. demonstrated that peritumoral delivery of heteromeric IL-15 led to an effective suppression of E0771 orthopically implanted tumors 56, 57, thus, demonstrating the direct anti-tumorigenic properties of IL-15 in this in vivo model of BC.